Skip to content
Clinical Trials – home
Verifiedinfo

Ośrodek Badań Klinicznych "METABOLICA" lek. Robert Witek

Poland Ul. Najswietszej Marii Panny 9b, 33-100 Tarnow, Poland

  • 7 trials recruiting
  • Type 2 diabetes mellitus · Obesity · Cardiac failure
  • Adult patients

About Specializations

Ośrodek Badań Klinicznych "METABOLICA" lek. Robert Witek in Tarnow, Poland specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Cardiac failure, Hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for ulcerative colitis. The ongoing studies aim to enhance patient outcomes through advanced therapeutic strategies.

  • Ulcerative Colitis
  • Endoscopic Improvement
  • Symptomatic Remission

By exploring the efficacy and safety of novel compounds, the center contributes significantly to the understanding and management of chronic gastrointestinal conditions.

Cardiology

Specializing in cardiology, the center is dedicated to advancing treatment options for chronic heart failure. Research efforts are concentrated on reducing cardiovascular risks and improving patient quality of life.

  • Heart Failure with Reduced Ejection Fraction
  • Cardiovascular Risk Reduction
  • Heart Failure Hospitalization

The center's work in this field is pivotal in developing therapies that address the complex needs of heart failure patients, aiming for long-term health improvements.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Najswietszej Marii Panny 9b33-100 TarnowPoland
Recruiting now
7 trials
Conditions studied
10
Partner status
Verified

More sites in TarnowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

20 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ALN-4324
  • Sponsor:Alnylam Pharmaceuticals Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7795081
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.